Editorially Independent Content, Supported With Advertising From Astellas and Carl Zeiss Meditec
John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH
Show Description +
Can rapid GA progression reshape follow-up and dosing decisions? Case presenter Margaret Chang, MD, MS, shares the case of an 82-year-old casino owner with foveal-involving GA in his right eye. Moderator John Kitchens, MD, and panelists Ferhina Ali, MD, MPH and David Eichenbaum, MD, review how to rely on imaging to help explain GA progression, discuss why selecting every-other-month versus monthly therapy is sometimes useful, and ask whether continuing treating the worse-seeing eye is warranted when vision become very bad. The team also covers caregiver engagement, leveraging manufacturer patient-facing literature, and why annual follow-ups can miss fast GA progression.
Posted: 9/24/2025
John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH
Can rapid GA progression reshape follow-up and dosing decisions? Case presenter Margaret Chang, MD, MS, shares the case of an 82-year-old casino owner with foveal-involving GA in his right eye. Moderator John Kitchens, MD, and panelists Ferhina Ali, MD, MPH and David Eichenbaum, MD, review how to rely on imaging to help explain GA progression, discuss why selecting every-other-month versus monthly therapy is sometimes useful, and ask whether continuing treating the worse-seeing eye is warranted when vision become very bad. The team also covers caregiver engagement, leveraging manufacturer patient-facing literature, and why annual follow-ups can miss fast GA progression.
Posted: 9/24/2025
Please log in to leave a comment.